Shannon Doherty

Our hands-on strategy, collaborative planning, and data-rich dashboards allow you to see your marketing ROI more quickly and clearly than ever. Bypass the ambiguity with New York Ave 👇 https://ny-ave.com/ #NewYorkAve #FullService #MarketingAgency #DigitalMarketing #CentralFlorida #BrandDevelopment #WebsiteDesign #SocialMediaManagement #EmailMarketing #MediaProduction #SEO #SearchEngineOptimization #ManagedMarketing #OutsourcedMarketing #MarketingServices

3

Here's an article that dives a little deeper into the DPE takeaway focused on patient adherence and prescription abandonment. IPG Health SOLVE(D) | An IPG Health Company

19

1 Comment

What’s a relationship without trust? My colleagues, Kelly Boyle and Mike Olson, help to break down three ways agencies can foster more trusting, fruitful, and lasting client relationships: https://ow.ly/1QUi30sEPcv #Agencies #ClientRelationships #DigitalAdvertising

3

Is your brand strategy ready for the future? Check out these expert insights on enhancing patient trust and staying ahead of market challenges by integrating customer experience, leveraging data strategies, and navigating industry disruptions. ✅ Future-proof your brand strategy: https://okt.to/LT9gnW

 #healthcaremarketing #brandstrategy

1

Did you know that more than 80% of medical records consists of unstructured data such as genomics reports, imaging, labs, and clinician notes? With our recent partnership with Deep 6 AI the ability to glean clinical insights from that untapped percentage is now much easier through their AI/NLP technology and Magnolia Market Access HEOR/RWE expertise. Register below for next Thursday's webinar on this very topic and how you can gain access to these insights.

2

While each of the nine trends we identified is important on its own, three key tensions have become more acute over the past decade, and three key constants explain perpetual feelings people hold. Join us as we highlight some of these overarching insights. https://lnkd.in/gJVnq66y

2

'Even small changes can introduce a lot of factors we have to consider". Revisit our #InsightstoActivate webinar to hear experts from Ford, Regeneron, and Ipsos explain how brands can mitigate tomorrow’s risks by planning today. https://lnkd.in/gT6GzAit 🎞 revisit panel discussion 📚 read our detailed Point of View 🔦 explore our toolkit + Impact Story ❤️ bookmark our series

2

Incredibly proud to have collaborated with Schizophrenia & Psychosis Action Alliance on meeting design, facilitation, and reporting for their inaugural SPRING 2024 Summit. The report, Roadmap to Recovery, charts a course to transform our broken system of care, created through the groundbreaking collaboration of 125 stakeholders – including those diagnosed with #schizophrenia and their care partners; clinicians; judges; and community leaders.  What I love the most about the SPRING 2024 Summit is its multi-stakeholder model. People who live with the disease are often overlooked in efforts to identify solutions, yet all of these perspectives are critical if we are to effectively improve the schizophrenia journey. “Working together with all of the stakeholders who play a role in the diagnosis, treatment and support of people living with schizophrenia – with the voices of those living with this severe brain disease ringing the loudest – we will deliver on a roadmap designed to shatter the barriers to treatment, survival and recovery.” Kudos to S&PAA! Read the full report here: https://bit.ly/3YEHcev and join the vital movement toward a more inclusive and effective system of care.

19

2 Comments

It's important for every brand to understand its purpose and to express it through the 3 Essential Narratives and an authentic and resonant storytelling framework.

14

In the evolving landscape of #HealthcareMarketing, the #DTC approach presents both unprecedented opportunities and significant challenges. Join us on May 29 to hear from @David Reim and @Luk Arbuckle as they discuss increasing concern over the potential to identify individuals when health data is combined with consumer data. Learn more and register here: https://lnkd.in/eEvvuDWF

9

November 2024. Something all of us are probably actively trying to avoid discussing in social settings. But the different outcomes are something companies need to start planning for. Join Ipsos's May 22 Insights to Activate webinar, where experts from Ford, Regeneron, and Ipsos will explain how strategic foresight can help mitigate risk and set your brand up for success, regardless of who ends up in the White House. Check out our POV & webinar registration here! https://lnkd.in/eY7yqNYA

6

1 Comment

Doctors’ Emotional Connections…to Prescription Drug Brands? As residents of a brand-saturated culture, we all know how important brands are in our lives. For example, and to be extremely specific, the Pantone green shade (PMS 3425 C) of the Starbucks logo has a positive visceral effect on me. This reaction is triggered, no doubt, by the conditioning effects of their powerfully caffeinated beverages on dopamine release in my brain over the course of a lifetime. When it comes to patients, it is easy to understand how someone could come to love a medication, based on how quickly and reliably it relieves their distressing symptoms. Conversely, many people come to hate a medication, because of the burdensome nature of the dosing, the taste of the liquid, or the unpleasant side effects. But what about doctors? Are prescription drugs simply simply tools of their trade that they view in a neutral, dispassionate manner? I think not. I maintain that doctors can have strong emotional reactions to Rx medications. When I practiced emergency medicine, there were some medications in which I had great confidence and which I enjoyed administering because of how well, how quickly, and how consistently they worked. IV adenosine for supraventricular tachycardia comes to mind. Being able to control an SVT instantly with a simple injection made me feel wonderful, powerful, almost god-like. Other medications made me uncomfortable through repeated associations with negative situations. For example, ketorolac (an injectable NSAID) was introduced with great fanfare as a potent non-opioid pain reliever. But, as soon as we started using it, patients whom we suspected of drug-seeking behavior claimed to be allergic to it. This led to a series of stressful and contentious encounters in our emergency department. And consider the challenging matter of drug compliance. How often do doctors prescribe medications while suspecting, in the back of their minds, that their patient will not take the drug as recommended because its dosing schedule is unrealistic? How does that make doctors feel? Then there are the high-priced treatments that the doctor knows, even as they prescribe the medication through the EHR, will lead to pushback from the payor based on cost or prior authorization requirements, leading to additional paperwork and treatment delays. These are just a few examples of a curious, sometimes impactful, though rarely discussed, emotional aspect of being a prescriber.

2

Discover the power of #ValueBasedCare (VBC)! By aligning incentives with patient health, ChenMed has helped reduce hospitalizations by 23%. Click below to learn how #VBC is transforming healthcare for the better! 👇 https://ow.ly/h4NR30sFly3 #Healthcare

2

Unlock practical strategies for shifting to a “human-to-human” business approach in this event from SCORR Marketing and Advanced Clinical. https://lnkd.in/gRTUf_Rs

6